TOKENPOST
1 min read
Add as a preferred source on Google

Bitwise Files for AI Drug Discovery ETF Focused on Medicine Development

The proposed fund would target AI applications in drug development. Bitwise previously proposed AI funds focused on network defense and bonds.

By Enna Lee
Published
A robotic pipette arm works over a drug discovery assay plate / TokenPost.ai (macro)
A robotic pipette arm works over a drug discovery assay plate / TokenPost.ai (macro)

Bitwise has filed for an exchange-traded fund focused on artificial intelligence in drug discovery, proposing an investment product tied to AI use in the process of developing medicines.

Bitwise previously proposed the Bitwise AI Network Defense ETF and Bitwise AI Bond ETF, which targeted AI in network defense and bonds.

Enna Lee

Reporter

Enna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…